Who has invested in Inversago Pharma?

Novo Nordisk, Forbion Ventures are named among the investors backing Inversago Pharma.

Inversago Pharma Funding: $110M Raised, Growth (2023)

Inversago Pharma funding overview

Inversago Pharma is based in Montreal, Canada. Inversago Pharma has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in August 2023. The round record for Inversago Pharma runs through 2023; nothing later has been disclosed. Investors on record include Novo Nordisk, Forbion Ventures. 2 distinct backers are named across the disclosed rounds.

Inversago Pharma at a glance

Total raised: $110M
Latest round: Growth
Latest round date: August 2023
Headquarters: Montreal, Canada
Notable investors: Novo Nordisk, Forbion Ventures

Frequently asked about Inversago Pharma funding

How much has Inversago Pharma raised?: Inversago Pharma has raised $110M in total disclosed funding across the rounds on record.
Who has invested in Inversago Pharma?: Novo Nordisk, Forbion Ventures are named among the investors backing Inversago Pharma.
What was the latest Inversago Pharma funding round?: The most recent disclosed round is a Growth, announced in August 2023.
Where is Inversago Pharma based?: Inversago Pharma is based in Montreal, Canada.
When did Inversago Pharma last raise?: The last disclosed Inversago Pharma round closed in August 2023 at Growth.

Every Inversago Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Montreal at a similar stage.

Inversago Pharma Funding: $110M Raised, Growth (2023)

Inversago Pharma funding overview

Inversago Pharma at a glance

Frequently asked about Inversago Pharma funding

Companies related to Inversago Pharma (22)

Browse related funding lists (3)